---
title: "Quantum BioPharma Ltd. (QNTM.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/QNTM.US.md"
symbol: "QNTM.US"
name: "Quantum BioPharma Ltd."
industry: "制药"
---

# Quantum BioPharma Ltd. (QNTM.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [www.quantumbiopharma.com](https://www.quantumbiopharma.com) |

## Company Profile

量子生物制药有限公司及其子公司作为一家生物制药公司运营。它通过两个部门运作，分别是生物制药创新和战略投资。该公司研究和开发一系列资产和生物技术解决方案，用于治疗神经退行性疾病、炎症性疾病和代谢性疾病，以及酒精滥用障碍，药物候选者处于不同的开发阶段。其主要化合物是 Lucid-MS，这是一种专利的新化学实体，目前正在进行第二阶段临床试验，以防止和逆转髓鞘退化，这是多发性硬化症的基本机制，在临床前模型中进行研究

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.48 | 87/257 | - | - | - |
| PB | 1.57 | 75/257 | 14.88 | 4.68 | 1.67 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-11T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 3.55 |

## References

- [Company Overview](https://longbridge.com/en/quote/QNTM.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/QNTM.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/QNTM.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.